121 related articles for article (PubMed ID: 35165222)
21. Association Between Surgeon-Specific Features and Number of Stages, Flaps, and Grafts in Mohs Micrographic Surgery: A Retrospective Observational Study of 59 Early-, Mid-, and Advanced-Career Mohs Surgeons.
Alhaddad M; Zade J; Nabatian A; Kriegel D; Khorasani H
Dermatol Surg; 2017 Nov; 43(11):1358-1362. PubMed ID: 28538031
[TBL] [Abstract][Full Text] [Related]
22. A process evaluation of the improving wisely intervention: a peer-to-peer data intervention to reduce overuse in surgery.
Fahim C; Bruhn WE; Albertini JG; Makary MA
BMC Health Serv Res; 2021 Jan; 21(1):100. PubMed ID: 33514362
[TBL] [Abstract][Full Text] [Related]
23. A Survey of American College of Mohs Surgery Videography Practices.
Hagstrom EL; Haynes D; Latour E; Leitenberger JJ
Dermatol Surg; 2021 May; 47(5):714-716. PubMed ID: 32826601
[No Abstract] [Full Text] [Related]
24. Practice Patterns and Job Satisfaction of Mohs Surgeons.
Kohli N; Golda N
Dermatol Surg; 2018 Jan; 44(1):42-47. PubMed ID: 29140863
[TBL] [Abstract][Full Text] [Related]
25. A Cross-Sectional Analysis of Sharps Injuries Among Dermatologic Surgeons: A Survey of American College of Mohs Surgery Members.
Talebi-Liasi F; Lewin JM
Dermatol Surg; 2023 Nov; 49(11):985-988. PubMed ID: 37643220
[TBL] [Abstract][Full Text] [Related]
26. Quantifying Utilization of Skin Substitutes by Mohs Micrographic Surgeons: A Cross-Sectional Analysis of Medicare Data.
Castner NB; Slutsky JB
Dermatol Surg; 2021 Nov; 47(11):1505-1506. PubMed ID: 34417385
[No Abstract] [Full Text] [Related]
27. Characteristics of Opioid Prescriptions by Mohs Surgeons in the Medicare Population.
Feng H; Kakpovbia E; Petriceks AP; Feng PW; Geronemus RG
Dermatol Surg; 2020 Mar; 46(3):335-340. PubMed ID: 31356436
[TBL] [Abstract][Full Text] [Related]
28. Association between type of reconstruction after Mohs micrographic surgery and surgeon-, patient-, and tumor-specific features: a cross-sectional study.
Alam M; Helenowksi IB; Cohen JL; Levy R; Liégeois N; Mafong EA; Mooney MA; Nehal KS; Nguyen TH; Ratner D; Rohrer T; Schmults CD; Tan S; Yoon J; Kakar R; Rademaker AW; White LE; Yoo S
Dermatol Surg; 2013 Jan; 39(1 Pt 1):51-5. PubMed ID: 23199073
[TBL] [Abstract][Full Text] [Related]
29. Antibiotic Practices in Mohs Micrographic Surgery.
Lin MJ; Dubin DP; Giordano CN; Kriegel DA; Khorasani H
J Drugs Dermatol; 2020 May; 19(5):493-497. PubMed ID: 32484626
[TBL] [Abstract][Full Text] [Related]
30. Use of physician assistants in Mohs micrographic surgery: a survey of fellowship-trained Mohs micrographic surgeons.
Hyde MA; Hadley ML; Roberson C; Jacobson A; Pappas L; Bowen GM
Dermatol Surg; 2010 Nov; 36(11):1700-3. PubMed ID: 20961351
[TBL] [Abstract][Full Text] [Related]
31. Association between number of stages in Mohs micrographic surgery and surgeon-, patient-, and tumor-specific features: a cross-sectional study of practice patterns of 20 early- and mid-career Mohs surgeons.
Alam M; Berg D; Bhatia A; Cohen JL; Hale EK; Herman AR; Huang CC; Jiang SI; Kimyai-Asadi A; Lee KK; Levy R; Rademaker AW; White LE; Yoo SS
Dermatol Surg; 2010 Dec; 36(12):1915-20. PubMed ID: 21040123
[TBL] [Abstract][Full Text] [Related]
32. Nicotinamide for Keratinocyte Carcinoma Chemoprevention: A Nationwide Survey of Mohs Surgeons.
Desai S; Olbricht S; Ruiz ES; Hartman RI
Dermatol Surg; 2021 Apr; 47(4):452-453. PubMed ID: 33625146
[TBL] [Abstract][Full Text] [Related]
33. Utilization Patterns of Fellowship-Trained Mohs Surgeons in the Treatment of Melanoma in Situ and Melanoma.
Barklund JS; Cameron MC; Mirhossaini RB; Brown M
Dermatol Surg; 2021 Jun; 47(6):814-815. PubMed ID: 32932262
[No Abstract] [Full Text] [Related]
34. Management of High-Risk Cutaneous Squamous Cell Carcinomas Among Mohs Surgeons.
Schwartz Z; Kurtyka D; Trufant J
Dermatol Surg; 2024 Jul; 50(7):674-675. PubMed ID: 38530992
[No Abstract] [Full Text] [Related]
35. Do Patterns of Reconstruction Choices After Mohs Surgery Vary by Specialty? A Pilot Study of Mohs Surgeons and Facial Plastic Surgeons.
Kurta AO; Sarhaddi D; Sheikh UA; Bernstein M; Walen S; Armbrecht ES; Maher IA
Dermatol Surg; 2018 Nov; 44(11):1396-1401. PubMed ID: 30045106
[TBL] [Abstract][Full Text] [Related]
36. Mohs surgeon workforce survey: a spectrum of clinical, academic, and leadership activities.
Scott JF; Lam C; Ahn JW; Yu SH
Arch Dermatol Res; 2023 Dec; 316(1):30. PubMed ID: 38060032
[TBL] [Abstract][Full Text] [Related]
37. Tumor Debulking Trends for Keratinocyte Carcinomas Among Mohs Surgeons.
Alniemi DT; Swanson AM; Lasarev M; Xu YG
Dermatol Surg; 2021 Dec; 47(12):1660-1661. PubMed ID: 34818278
[No Abstract] [Full Text] [Related]
38. Communication Strategies in Mohs Micrographic Surgery: A Survey of Methods, Time Savings, and Perceived Patient Satisfaction.
Yousefi N; McLawhorn JM; Quinn A; Stubblefield A; Chen S; Stasko T; Collins L
Cutis; 2021 May; 107(5):249-252. PubMed ID: 34288852
[TBL] [Abstract][Full Text] [Related]
39. Adoption of Human Papillomavirus Vaccination Among Dermatologic Surgeons: A Survey Study of American College of Mohs Surgery Members.
Pearlman RL; Condie DL; Nahar VK; Black WH
Dermatol Surg; 2022 Mar; 48(3):373-376. PubMed ID: 35025847
[No Abstract] [Full Text] [Related]
40. Margin Size for Unique Skin Tumors Treated With Mohs Micrographic Surgery: A Survey of Practice Patterns.
Walocko FM; Carr C; Srivastava D; Nijhawan RI
Cutis; 2022 Sep; 110(3):E21-E24. PubMed ID: 36446119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
